Researchers have reversed Alzheimer’s symptoms in mice using bioactive nanoparticles that restore blood-brain barrier function. The therapy rapidly cleared toxic amyloid-beta and improved behavior, highlighting vascular health as a promising new target for human Alzheimer’s treatments.
